Access to anti-retroviral drugs, female in Least developed countries
Least developed countries: Access to anti-retroviral drugs, female was 86.4% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Least developed countries, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Least developed countries stood at 86.4%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.3% on the previous year and up 87.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Least developed countries peaked at 86.4% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Least developed countries, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.1% | +913.2% |
| 2003 | 0.5% | +293.3% |
| 2004 | 1.7% | +221.9% |
| 2005 | 3.5% | +108.3% |
| 2006 | 6.2% | +78.7% |
| 2007 | 10.8% | +72.6% |
| 2008 | 15.0% | +39.0% |
| 2009 | 18.7% | +25.2% |
| 2010 | 23.1% | +23.2% |
| 2011 | 26.9% | +16.4% |
| 2012 | 32.4% | +20.5% |
| 2013 | 38.7% | +19.7% |
| 2014 | 46.2% | +19.2% |
| 2015 | 50.8% | +10.1% |
| 2016 | 56.1% | +10.3% |
| 2017 | 62.3% | +11.1% |
| 2018 | 65.1% | +4.6% |
| 2019 | 69.2% | +6.2% |
| 2020 | 73.3% | +6.0% |
| 2021 | 75.9% | +3.6% |
| 2022 | 79.6% | +4.8% |
| 2023 | 82.8% | +4.0% |
| 2024 | 86.4% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.6% | 0.0% | 18.7% | 10 |
| 2010s | 47.1% | 23.1% | 69.2% | 10 |
| 2020s | 79.6% | 73.3% | 86.4% | 5 |
Countries ranked near Least developed countries
- 12 Rwanda 97.0% compare
- 12 United Arab Emirates 97.0% compare
More gender data for Least developed countries
- Labor force, female 190.69 million (2025)
- Labor force, female, per capita 0.157 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.77 % change on previous year (2025)
- Labor force, female, per square kilometre 9.08 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.5909 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.3771 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.7852 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.3129 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 111.6% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Least developed countries?
- Access to anti-retroviral drugs, female in Least developed countries was 86.4% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Least developed countries?
- The highest recorded value was 86.4% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Least developed countries?
- The lowest recorded value was 0.0% in 2000.
- How does Least developed countries rank for access to anti-retroviral drugs, female?
- Least developed countries ranks 9th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Least developed countries?
- Over the last ten years it is up 87.1%. The long-run trend across the full record is volatile.
- Where does this Least developed countries data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.